The Canine Review

All issues

Trupanion stock plunge persists, CEO stays silent, loss ratios rise

Trupanion stock plunge persists, CEO stays silent, loss ratios rise

image




Trupanion stock plunge persists, CEO stays mum, loss ratios rise

image


Trupanion’s stock price continued to decline late Tuesday afternoon. It’s been a rough eighteen months for the Seattle-based pet insurer, whose stock price has been on a downward trend since early 2022, now dipping below $20 to new 52-week low. We’re trying to match the timeline of the stock fall-off with events affecting the company and the industry to understand if and how Trupanion’s prospects have declined as much as its market cap.


Other questions that remain to be answered are consequential, not only for Trupanion, but for veterinary medicine and for the pet insurance market in North America. So, TCR reached out to Trupanion’s Board of Directors – each person individually – for input. We also contacted several managers, advisors, former employees, and industry stakeholders.


We’ve had several helpful responses, but we’re still hoping more of you will contribute to our reporting. Please be in touch.




FOR NEW READERS

Get To Know The Canine Review

Vet Podcast Appearance Discussing Journalism and Why TCR

 TCR Policies PDF Distributed To All Reporters

How We Gather The News And Other Questions Readers Have Been Asking Lately (Updated April 2023) 

Is it true that TCR bans the use of the term “investigative journalism” ?

MORE


Exclusive: FDA releases diet-associated dog DCM case reports via FOIA after two-year battle

image


The Canine Review received records by email responding to a Freedom of Information Act request we filed earlier this year. See FOIA documents and other communications below. Although the records seem to stop at November 3, 2022, the cut-off date of the December 23, 2022 case count update […]






Stories You May Have Missed

Vet Industry Leaders Fault AVMA for Reticence on Key Issues

VIN News tries to catch up with TCR

USA Today ambushes Seresto again with dubious story, failing to seek comment

Trupanion CEO Addresses Wall Street Concerns Following Ousting of Three Top Executives; Engages on Regulatory Environment

VEG CEO Attacks Pet Insurers, Offers ‘No Solution’ For Those Who Can’t Pay Vet Bills Up Front

Pet Food Company Targets, Taunts Veterinarians


To subscribe and start receiving the latest news and updates straight to your inbox, simply click the button below.


Join The Canine Review



image

Share
Get the next issue in your inbox
Free, and you can unsubscribe any time.

0 comments

More issues

All 5 →
#2 May 17, 2023

Trupanion stock plunge persists, CEO stays silent, loss ratios rise

Read issue →
#1 May 16, 2023

Trupanion stock plunge persists, CEO stays silent, loss ratios rise

Read issue →